Aclarion (ACON)

• Market cap: $1.3M
• 1 day: 8.99%
• 5 days: 13.55%
• 1 month: -29.20%
• 3 months: -29.44%
• 6 months: -56.56%
• Year to date: -96.24%
• 1 year: -97.76%
• 5 years: -99.71%
• 10 years: -99.71%
• Sector: Healthcare
• Industry: Medical Laboratories

About: Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

Employees: 6

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

0% more funds holding

Funds holding: 9 [Q2] → 9 (+0) [Q3]

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

0.3% less ownership

Funds ownership: 4.01% [Q2] → 3.71% (-0.3%) [Q3]

27% less capital invested

Capital invested by funds: $94.2K [Q2] → $68.4K (-$25.8K) [Q3]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $1.30 941% upside
• Avg. target: $1.30 941% upside
• High target: $1.30 941% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Ascendiant Capital Lucas Ward 33% 1-year accuracy 4 / 12 met price target

941% upside $1.30

Buy Maintained

27 Nov 2024